Power Solutions

Vicor Power Systems introduces a new family of VITA 62 compliant power supplies for MIL-COTS VPX applications

Vicor Power Systems new line of VITA 62 compliant power supplies are designed for 3U Open VPX systems and achieve high-efficiency and high-power density in a rugged, conduction-cooled chassis. The initial products operate from a nominal 28V or 270V DC input, with predefined output voltages ranging from 3.3V to 12V, delivering up to 600W of power. Customers requiring different output voltages or power levels can request a customized power supply to meet their own specifications.

This family of products has been fully tested and will meet MIL-461F and MIL-704F.  In addition, the 28V input version also meets MIL-1275D.  See datasheet for compliance information.

Lihi

Recent Posts

Tower Semiconductor Secures $1.3 Billion Silicon Photonics Agreements and Reports Strong Q1 2026 Growth

Tower Semiconductor announced that it has signed silicon photonics agreements valued at $1.3 billion for…

2 days ago

14 Israeli Cybersecurity Companies Named to the Rising in Cyber 2026 List of the World’s Most Promising Cyber Startups

The report is based on a survey of 150 CISOs and senior cybersecurity leaders from…

2 days ago

Sequent Selected by 15 Canadian Municipalities to Deliver Verifiable, Trust-Based Digital Voting for Elections

More than 200,000 voters will cast ballots using a secure and cryptographically verified online voting…

2 days ago

Sheba and Ichilov Medical Centers Join AccuLine’s International Clinical Trial for AI-Driven Early Heart Attack Risk Assessment

The multi-center study, involving 2,000 patients, will validate the CORA system - a breakthrough AI…

2 days ago

Molex Completes Acquisition of Teramount Ltd.

Molex, a global electronics leader and connectivity innovator, has completed the acquisition of Teramount Ltd.,…

5 days ago

Immunai Expands Oncology Collaboration, Extending AI-Driven Biomarker and Clinical Insights Through 2027

This agreement marks the third expansion of its collaboration with AstraZeneca, building on collaborations in…

6 days ago